$4.58-0.06 (-1.29%)
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.
Tilray Brands, Inc. in the Healthcare sector is trading at $4.58 with a market capitalization of $611M. Wall Street consensus targets $9.66 (9 analysts), implying a +110.8% move over the next 12 months. The stock is currently near its 52-week low of $3.90, remaining 48.7% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $206.73M↓ | $217.51M↑ | $209.50M↓ | $224.53M↑ | $185.78M |
| Gross Profit | $54.95M↓ | $57.50M | $57.47M↓ | $67.63M↑ | $52.01M |
| Operating Income | -$19.87M↑ | -$20.01M↓ | -$10.87M↑ | -$12.66M↑ | -$31.40M |
| Net Income | -$26.57M↑ | -$44.93M↓ | -$322,000↑ | -$1.27B↓ | -$789.44M |
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The compan...
In the closing of the recent trading day, Tilray Brands, Inc. (TLRY) stood at $4.46, denoting a -2.83% move from the preceding trading day.
Cronos Group posts 40% Q1 revenue growth, gains share in Canada and expands abroad, but fierce cannabis competition keeps investors cautious.
In the closing of the recent trading day, Tilray Brands, Inc. (TLRY) stood at $4.59, denoting a -2.96% move from the preceding trading day.
Tilray Brands tried one thing, and it didn't work; now it is trying another approach.
The brand, said to "deliver clean, refreshing energy", is being sold online through Amazon and BrewDog's website.